Systemic administration of a matrix-targeted retroviral vector is efficacious for cancer gene therapy in mice.

Source:http://linkedlifedata.com/resource/pubmed/id/11177556

Hum. Gene Ther. 2001 Jan 20 12 2 193-204

Download in:

View as

Triples

General Info

PMID
11177556